- Home
- ROIV vs RMBS Comparison
ROIV vs RMBS Comparison
Compare ROIV & RMBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- RMBS
- Stock Information
- Founded
- ROIV 2014
- RMBS 1990
- Country
- ROIV United Kingdom
- RMBS United States
- Employees
- ROIV N/A
- RMBS N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- RMBS Semiconductors
- Sector
- ROIV Health Care
- RMBS Technology
- Exchange
- ROIV Nasdaq
- RMBS Nasdaq
- Market Cap
- ROIV 8.6B
- RMBS 8.0B
- IPO Year
- ROIV N/A
- RMBS 1997
- Fundamental
- Price
- ROIV $16.66
- RMBS $96.68
- Analyst Decision
- ROIV Strong Buy
- RMBS Strong Buy
- Analyst Count
- ROIV 8
- RMBS 6
- Target Price
- ROIV $19.94
- RMBS $97.83
- AVG Volume (30 Days)
- ROIV 8.3M
- RMBS 2.6M
- Earning Date
- ROIV 11-11-2025
- RMBS 10-27-2025
- Dividend Yield
- ROIV N/A
- RMBS N/A
- EPS Growth
- ROIV N/A
- RMBS 0.94
- EPS
- ROIV N/A
- RMBS 2.11
- Revenue
- ROIV $23,233,000.00
- RMBS $645,488,000.00
- Revenue This Year
- ROIV N/A
- RMBS $27.27
- Revenue Next Year
- ROIV $200.91
- RMBS $13.97
- P/E Ratio
- ROIV N/A
- RMBS $44.85
- Revenue Growth
- ROIV N/A
- RMBS 35.17
- 52 Week Low
- ROIV $8.73
- RMBS $40.12
- 52 Week High
- ROIV $16.79
- RMBS $109.15
- Technical
- Relative Strength Index (RSI)
- ROIV 78.13
- RMBS 55.46
- Support Level
- ROIV $15.91
- RMBS $90.00
- Resistance Level
- ROIV $16.39
- RMBS $97.59
- Average True Range (ATR)
- ROIV 0.48
- RMBS 5.20
- MACD
- ROIV -0.02
- RMBS -1.47
- Stochastic Oscillator
- ROIV 92.05
- RMBS 34.88
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About RMBS Rambus Inc.
Rambus Inc is a semiconductor solutions provider offering high-speed, high-security computer chips and Silicon intellectual property. The company's key products include memory interface chips, built for high speed and efficiency; silicon IP, providing high-speed memory and chip-to-chip connection technology; and architecture licenses, which allow customers to use portions of Rambus' patented inventions for their own digital electronics. The firm receives the majority of its revenue from the United States, Taiwan, Asia, Japan, and Singapore.